1. Home
  2. UTZ vs AKBA Comparison

UTZ vs AKBA Comparison

Compare UTZ & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTZ
  • AKBA
  • Stock Information
  • Founded
  • UTZ 2018
  • AKBA 2007
  • Country
  • UTZ United States
  • AKBA United States
  • Employees
  • UTZ N/A
  • AKBA N/A
  • Industry
  • UTZ Packaged Foods
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTZ Consumer Staples
  • AKBA Health Care
  • Exchange
  • UTZ Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • UTZ 1.1B
  • AKBA 958.6M
  • IPO Year
  • UTZ N/A
  • AKBA 2014
  • Fundamental
  • Price
  • UTZ $14.32
  • AKBA $3.56
  • Analyst Decision
  • UTZ Buy
  • AKBA Strong Buy
  • Analyst Count
  • UTZ 8
  • AKBA 5
  • Target Price
  • UTZ $17.88
  • AKBA $6.90
  • AVG Volume (30 Days)
  • UTZ 1.1M
  • AKBA 3.5M
  • Earning Date
  • UTZ 07-31-2025
  • AKBA 08-07-2025
  • Dividend Yield
  • UTZ 1.71%
  • AKBA N/A
  • EPS Growth
  • UTZ N/A
  • AKBA N/A
  • EPS
  • UTZ 0.32
  • AKBA N/A
  • Revenue
  • UTZ $1,414,842,000.00
  • AKBA $184,909,000.00
  • Revenue This Year
  • UTZ $2.61
  • AKBA $26.88
  • Revenue Next Year
  • UTZ $2.70
  • AKBA $44.34
  • P/E Ratio
  • UTZ $44.12
  • AKBA N/A
  • Revenue Growth
  • UTZ N/A
  • AKBA N/A
  • 52 Week Low
  • UTZ $11.53
  • AKBA $1.07
  • 52 Week High
  • UTZ $18.89
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • UTZ 64.30
  • AKBA 43.13
  • Support Level
  • UTZ $13.98
  • AKBA $3.77
  • Resistance Level
  • UTZ $14.67
  • AKBA $4.04
  • Average True Range (ATR)
  • UTZ 0.38
  • AKBA 0.17
  • MACD
  • UTZ 0.08
  • AKBA -0.04
  • Stochastic Oscillator
  • UTZ 81.70
  • AKBA 8.27

About UTZ Utz Brands Inc

Utz Brands Inc is a manufacturer of branded salty snacks. It produces a broad offering of salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, pub/party mixes, and other snacks. Its iconic portfolio of authentic, craft, and better-for-you (BFY) brands, which includes Utz, Zapp's, On The Border, Golden Flake, and Boulder Canyon, among others, enjoys household penetration in the United States, where its products can be found in approximately half of U.S. household. The company operates in eight manufacturing facilities with a broad range of capabilities, and its products are distributed nationally to grocery, mass, club, convenience, drug, e-commerce and other retailers through direct shipments, distributors, and approximately 2,500 DSD routes.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: